Company intelligence / Profile preview

Liora Technologies

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Liora Technologies developed the LiGHT System (Linac for Image Guided Hadron Therapy), an electronically controlled proton therapy platform for cancer treatment. The system is installed at STFC's Daresbury Laboratory with over $300 million invested in development.

Therapeutic areas: Oncology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Science and Technology Facilities Council (STFC)

Beyond the preview

Go deeper on Liora Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liora Technologies.

Explore the full profile